3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone(T-CHP) in Previously Untreated Patients With CD20-positive DLBCLB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmNot yet recruitingPhase 1 / Phase 22025-08-22NCT07035379
A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.CD20-positive Diffuse Large B-Cell LymphomaNot yet recruitingPhase 22025-08-22NCT06886139
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.CD20-positive B-cell Non-Hodgkin LymphomaActive, not recruitingPhase 12025-06-25NCT05395533